甲磺酸贝舒地尔片能有效治病吗？

Introduction: Besudil mesylate tablets are a prescription drug used to treat adults and children 12 years and older with chronic graft-versus-host disease (chronic GVHD), provided that they have received at least 2 previous treatments (systemic therapy), but these treatments have been ineffective. It is not known whether Besudil mesylate tablets are safe and effective in children under 12 years of age.

Can the generic version of Besudil mesylate tablets also be effective in treating diseases

There are currently generic drugs on the market that can also effectively treat chronic graft-versus-host disease. At present, the more common generic version is produced by Lucius Pharmaceuticals. Compared with the price of the original drug, the generic version of Besudil Mesylate Tablets is cheaper.

A generic drug refers to a drug that is identical to the original drug in terms of dosage, safety, efficacy, quality, effects and indications. If the generic version of Besudil Mesylate Tablets has been approved by the corresponding drug regulatory authorities and follows the same quality standards and production practices as the original drug, its therapeutic effect should be basically the same as the original drug.

It should be noted that even for generic drugs, small differences in the production process may affect the bioequivalence of the drug. Therefore, patients should seek the advice of a doctor or medical professional when using generic drugs and ensure that they are obtained from reliable and legal sources.

The price of Besudil Mesylate Tablets

Currently, it is understood that the winning bid price of Besudil Mesylate Tablets included in the medical insurance version ranges from 20,418$ to 40,888$. The price after medical insurance reimbursement will be cheaper. In addition, the specification of Besudil mesylate tablets produced by Lucius is 200mg*30 tablets per box, and the price of a box is about 4050$-4500$.

It may be affected by many factors, including region, medical insurance policy, drug version, etc., so the price may change. If you need to purchase this drug, it is recommended to contact the drug supplier or health care provider directly to obtain the latest price information.

Adverse reactions of Besudil mesylate tablets

The most common adverse reactions of Besudil mesylate tablets include laboratory abnormalities, which are infection, fatigue, nausea, diarrhea, dyspnea, cough, edema, bleeding, abdominal pain, musculoskeletal pain, headache, decreased phosphate, increased gamma-glutamyl transferase, lymphopenia and hypertension.

18% of patients permanently stopped taking Besudil Mesylate Tablets due to adverse reactions, and >3% of patients permanently stopped taking Besudil Mesylate Tablets. Adverse reactions included nausea. Adverse reactions leading to dose interruption in ≥2% of patients included infection, diarrhea, as well as fatigue, dyspnea, bleeding, hypotension, abnormal liver function tests, nausea, pyrexia, edema, and renal failure.

It should be noted that Besudil Mesylate Tablets should be avoided in patients with moderate or severe hepatic impairment and no liver graft-versus-host disease. For patients with mild hepatic impairment, no dose adjustment is recommended.